Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 16802 | 635 | 50.7 | 95% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 262 | 3 | AUTOPHAGY//RESVERATROL//HISTONE DEACETYLASE INHIBITOR | 44558 |
| 1531 | 2 | HISTONE DEACETYLASE INHIBITOR//HISTONE DEACETYLASE//HDAC INHIBITOR | 7464 |
| 16802 | 1 | MEF2C//MEF2//MEF2D | 635 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | MEF2C | authKW | 514985 | 6% | 30% | 36 |
| 2 | MEF2 | authKW | 455886 | 7% | 22% | 43 |
| 3 | MEF2D | authKW | 423370 | 3% | 46% | 19 |
| 4 | HDAC4 | authKW | 307715 | 4% | 27% | 24 |
| 5 | CLASS IIA HDACS | authKW | 192344 | 1% | 100% | 4 |
| 6 | MYOCYTE ENHANCER FACTOR 2A | authKW | 153873 | 1% | 80% | 4 |
| 7 | HDAC9 | authKW | 129819 | 1% | 30% | 9 |
| 8 | HDAC5 | authKW | 129281 | 2% | 24% | 11 |
| 9 | MYOCYTE ENHANCER FACTOR 2 | authKW | 119367 | 2% | 21% | 12 |
| 10 | MEF2C GENE | authKW | 108192 | 0% | 75% | 3 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cell Biology | 2104 | 30% | 0% | 192 |
| 2 | Biochemistry & Molecular Biology | 1577 | 43% | 0% | 270 |
| 3 | Cardiac & Cardiovascular System | 404 | 11% | 0% | 70 |
| 4 | Genetics & Heredity | 318 | 11% | 0% | 67 |
| 5 | Peripheral Vascular Diseases | 287 | 7% | 0% | 44 |
| 6 | Developmental Biology | 220 | 4% | 0% | 26 |
| 7 | Neurosciences | 149 | 11% | 0% | 72 |
| 8 | Hematology | 114 | 5% | 0% | 31 |
| 9 | Physiology | 74 | 5% | 0% | 30 |
| 10 | Medicine, Research & Experimental | 74 | 5% | 0% | 33 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ROGER WILLIAM MED | 59177 | 1% | 31% | 4 |
| 2 | ADDENBROOKES CLIN INVEST BLDG | 48086 | 0% | 100% | 1 |
| 3 | AREA CORAZON FUNDACIO FDN ASTURCOR | 48086 | 0% | 100% | 1 |
| 4 | BIOCHEM MOL BIL | 48086 | 0% | 100% | 1 |
| 5 | BIOL VASC TEREPIA GENICA | 48086 | 0% | 100% | 1 |
| 6 | BIOL VASCOLARE MED RIGENERATIVA | 48086 | 0% | 100% | 1 |
| 7 | BIOMED SCI BIOCHEM MOL BIOLI EM HYPOX | 48086 | 0% | 100% | 1 |
| 8 | BRAIN KOREA KYUNGPOOK UNIV BIOMED CONVERGENC | 48086 | 0% | 100% | 1 |
| 9 | BRITISH HEART FDN ST THOMAS HOSP | 48086 | 0% | 100% | 1 |
| 10 | CARDIOVASCULAR EPIGENET | 48086 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | MOLECULAR AND CELLULAR BIOLOGY | 1907 | 5% | 0% | 30 |
| 2 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1309 | 10% | 0% | 66 |
| 3 | CIRCULATION RESEARCH | 1049 | 2% | 0% | 15 |
| 4 | EPIGENOMICS | 931 | 0% | 1% | 3 |
| 5 | AMERICAN JOURNAL OF MEDICAL GENETICS PART A | 817 | 2% | 0% | 10 |
| 6 | JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 461 | 1% | 0% | 8 |
| 7 | CARDIOVASCULAR RESEARCH | 380 | 1% | 0% | 8 |
| 8 | EUROPEAN JOURNAL OF MEDICAL GENETICS | 375 | 0% | 0% | 3 |
| 9 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 372 | 1% | 0% | 6 |
| 10 | NEUROGENETICS | 314 | 0% | 0% | 2 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MEF2C | 514985 | 6% | 30% | 36 | Search MEF2C | Search MEF2C |
| 2 | MEF2 | 455886 | 7% | 22% | 43 | Search MEF2 | Search MEF2 |
| 3 | MEF2D | 423370 | 3% | 46% | 19 | Search MEF2D | Search MEF2D |
| 4 | HDAC4 | 307715 | 4% | 27% | 24 | Search HDAC4 | Search HDAC4 |
| 5 | CLASS IIA HDACS | 192344 | 1% | 100% | 4 | Search CLASS+IIA+HDACS | Search CLASS+IIA+HDACS |
| 6 | MYOCYTE ENHANCER FACTOR 2A | 153873 | 1% | 80% | 4 | Search MYOCYTE+ENHANCER+FACTOR+2A | Search MYOCYTE+ENHANCER+FACTOR+2A |
| 7 | HDAC9 | 129819 | 1% | 30% | 9 | Search HDAC9 | Search HDAC9 |
| 8 | HDAC5 | 129281 | 2% | 24% | 11 | Search HDAC5 | Search HDAC5 |
| 9 | MYOCYTE ENHANCER FACTOR 2 | 119367 | 2% | 21% | 12 | Search MYOCYTE+ENHANCER+FACTOR+2 | Search MYOCYTE+ENHANCER+FACTOR+2 |
| 10 | MEF2C GENE | 108192 | 0% | 75% | 3 | Search MEF2C+GENE | Search MEF2C+GENE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | PON, JR , MARRA, MA , (2016) MEF2 TRANSCRIPTION FACTORS: DEVELOPMENTAL REGULATORS AND EMERGING CANCER GENES.ONCOTARGET. VOL. 7. ISSUE 3. P. 2297 -2312 | 76 | 54% | 6 |
| 2 | WEEKS, KL , AVKIRAN, M , (2015) ROLES AND POST-TRANSLATIONAL REGULATION OF CARDIAC CLASS IIA HISTONE DEACETYLASE ISOFORMS.JOURNAL OF PHYSIOLOGY-LONDON. VOL. 593. ISSUE 8. P. 1785 -1797 | 52 | 54% | 5 |
| 3 | DI GIORGIO, E , BRANCOLINI, C , (2016) REGULATION OF CLASS IIA HDAC ACTIVITIES: IT IS NOT ONLY MATTER OF SUBCELLULAR LOCALIZATION.EPIGENOMICS. VOL. 8. ISSUE 2. P. 251 -269 | 56 | 40% | 3 |
| 4 | MARTIN, M , KETTMANN, R , DEQUIEDT, F , (2009) CLASS IIA HISTONE DEACETYLASES: CONDUCTING DEVELOPMENT AND DIFFERENTIATION.INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. VOL. 53. ISSUE 2-3. P. 291-301 | 63 | 45% | 31 |
| 5 | MATHIAS, RA , GUISE, AJ , CRISTEA, IM , (2015) POST-TRANSLATIONAL MODIFICATIONS REGULATE CLASS IIA HISTONE DEACETYLASE (HDAC) FUNCTION IN HEALTH AND DISEASE.MOLECULAR & CELLULAR PROTEOMICS. VOL. 14. ISSUE 3. P. 456 -470 | 58 | 36% | 6 |
| 6 | SHALIZI, AK , BONNI, A , (2005) BRAWN FOR BRAINS: THE ROLE OF MEF2 PROTEINS IN THE DEVELOPING NERVOUS SYSTEM.CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 69. VOL. 69. ISSUE . P. 239 -266 | 61 | 40% | 43 |
| 7 | LEHMANN, LH , WORST, BC , STANMORE, DA , BACKS, J , (2014) HISTONE DEACETYLASE SIGNALING IN CARDIOPROTECTION.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 71. ISSUE 9. P. 1673-1690 | 53 | 37% | 4 |
| 8 | MARTIN, M , KETTMANN, R , DEQUIEDT, F , (2007) CLASS IIA HISTONE DEACETYLASES: REGULATING THE REGULATORS.ONCOGENE. VOL. 26. ISSUE 37. P. 5450-5467 | 58 | 33% | 122 |
| 9 | TANTELES, GA , ALEXANDROU, A , EVANGELIDOU, P , GAVATHA, M , ANASTASIADOU, V , SISMANI, C , (2015) PARTIAL MEF2C DELETION IN A CYPRIOT PATIENT WITH SEVERE INTELLECTUAL DISABILITY AND A JUGULAR FOSSA MALFORMATION: REVIEW OF THE LITERATURE.AMERICAN JOURNAL OF MEDICAL GENETICS PART A. VOL. 167. ISSUE 3. P. 664 -669 | 20 | 95% | 0 |
| 10 | CANTE-BARRETT, K , PIETERS, R , MEIJERINK, JPP , (2014) MYOCYTE ENHANCER FACTOR 2C IN HEMATOPOIESIS AND LEUKEMIA.ONCOGENE. VOL. 33. ISSUE 4. P. 403-410 | 36 | 45% | 15 |
Classes with closest relation at Level 1 |